Abstract
Introduction
Atrial fibrillation (AF) is the commonest cardiac arrhythmia [1] . Developing effective and safe antiarrhythmic drugs remains challenging [1] and fraught with potential complications including promoting ventricular arrhythmias by prolonging action potential durations (APD). The atrial and ventricular fast Na+ currents (INa) show different properties in the voltagedependent inactivation of the channel, mediating the possibility for atrial-selective sodium channel block [2] . The ultra-rapid delayed rectifier potassium current (IKur) carried by Kv1.5 channel contributes to repolarization in the atria but not in the ventricles [3, 4] . Recent studies suggest that the atrial-selective blockade of IKur is a potentially effective strategy for the pharmacological treatment of AF [5] . Among the selective IKur blockers, Acacetin, a natural flavone initially isolated from a traditional Chinese medicine Xuelianhua, was demonstrated to be a promising atrial-selective agent for the treatment of AF [3, 5] .
Multiple-channel blockade is receiving growing interest as empirical observations suggest that multichannel blockers generally offer more effective antiarrhythmic effects [1] . A recent study with mathematical simulations and experimental validations on (presumably healthy) canine hearts suggest that adding potassium channel block enhances the AF-selective anti-AF effects obtainable from optimised INa blockade.
In this study we use computational models to assess the hypothesis that blocking IKur and INa might produce synergistic anti-arrhythmic effects in the chronic AF (cAF) remodelled human atria. The blockade of IKur and INa were simulated by modelling effects of Acacetin and optimised INa blockers using state-dependent blockade models, respectively. Single cell and tissue models were employed to simulate the anti-AF effects of individual and combined blockers.
Methods

Modelling human atrial electrophysiology
A recent mathematical model for human atrial electrophysiology [6] was employed to simulate the human atrial electrical activities under both sinus rhythm (SR) and cAF conditions. The formulation of IKur was updated based on recently published data [4] . cAF induced electrical remodelling were incorporated based on a previously published model (AF-4 in [6] ).
In simulating the effects of sodium blockers on human ventricular AP, the mathematical model published by O'Hara et al. [7] was adopted. The INa formulation in the ventricular model was replaced with that in [6] .
Modelling INa blocker
Following previous a study [1] on simulating INa blockade, a theoretically optimized INa blocker was used. We employed the guarded receptor model to simulate the binding and unbinding of drug to sodium channel in a drug concentration-dependent manner. It was assumed that the drug predominantly binds to the activated and inactivated states of the sodium channel (denoted as BA and BI, respectively). The blockade of INa is given by:
where gNa is the channel conductance of INa; BA and BI are the fractional activated and inactivated blocks; m is the activation gate, h and j are the inactivation variables of the sodium channel; V is the transmembrane potential; ENa is the reversal potential of Na + ; F, R and T are the Faraday's constant, universal gas constant and temperature respectively; KA, KI are the binding constants and LA, LI are the unbinding constants; [D] is the drug concentration; In the present study, a drug concentration .
Modelling effects of Acacetin
The effects of Acacetin on human atrial electrophysiology were simulated using the guarded receptor formalism. It was assumed that the drug binds to the open and closed gates of Kv1.5. Therefore, the binding and unbinding kinetics for open and closed states were functions of the binding constants, and given by: The binding and unbinding parameters were obtained by fitting the model to the experimental data from [3] , and are given in Table 1 . 
Two-dimensional tissue models
We performed two-dimensional simulations on a 7.5×7.5 cm 2 sheet of human atrial myocytes with 250 nodes along each direction. To solve the excitation wave propagation problem, the well-known mono-domain equation [6] was used, given by:
where V is the membrane potential, D is the diffusion parameter, Iion is the total ionic current in a single cardiomyocyte and Cm is the membrane capacitance of the cell. The tissue was modelled as homogeneous to conduction. The diffusion coefficient was chosen so that the model gives a conduction velocity of 0.7 m/s measured using plane wave for the tissue with normal human atrial cells. The numerical method used in our previous study [6] was adopted here. The mono-domain equation was integrated at a time step of 0.02 ms.
To initiate re-entrant waves, the cross field (S1-S2) protocol [1] was used. Life span of re-entrant excitations were quantified based on pseudo-ECG signals, which were computed using the equation as described in [8] .
Results
Effects of cAF on atrial electrophysiology
Incorporation of cAF induced electrical remodeling to the significantly reduced APD ( Figure 1A , 247 ms in SR versus 157 ms in the AF model). The calcium transient (CaT) was also markedly reduced with cAF remodeling ( Figure 1B) . 
Simulated effects of INa and IKur blocks on the electrophysiology of human cardiomyocytes
Individual and combined effects of INa and IKur blocks on human atrial and ventricular electrophysiology were simulated and the results are shown in Figure 2 . For a slow pacing rate (1Hz), blocking INa alone with the theoretical blocker rendered no significant effects on either AP or peak INa in both atrial and ventricular cells (Figure 2 A&C) . At 1Hz, applying acacetin prolonged APD by 29.3 ms. Combining INa and IKur blocks produced negligible change in APD (0.3 ms prolongation) and peak
INa.
At a fast pacing rate (6 Hz), alternans in APD and peak Ina were produced (Figure 2Bi ). Applying the INa blocker exerted pronounced reduction to peak INa and thus dVdtmax (143.7 versus 172.0 pA/pF for control, 17% reduction); APD was prolonged by 3.5 ms. Applying acacetin alone prolonged APD by 26.1 ms for big AP, and 38.1 ms for the small AP) and marked decrease in peak INa (by 28.2% for big AP, and 20.1% for small AP). More pronounced effects on AP were produced by combining IKur and INa blocks, showing more significant alternans in AP and dVdtmax; APD was prolonged by 55.8 ms for the big AP, demonstrating a synergistic effect in APD prolongation.
Simulated effects of INa and IKur blocks on AF termination
Re-entrant excitation waves were initiated in the twodimensional human atrial tissue. In simulating drug blocks, drugs were applied at 2500 ms following initiation of reentry. Figure 3 The application of both drugs exerted most effective termination of AF, with the reentries were sustained for only 1052 ms after applying drugs. 
Discussion and conclusion
Using biophysically detailed models of human cardiac electrophysiology, we show that state-dependent block of sodium channels exerted no effect at slow pacing rate and pronounced effects at fast rates. Combined INa and IKur blocks produced much more significant antiarrhythmic effects than an individual application of either blocker. In simulated AF, applying combined blocks was shown to be most effective in terminating rotors.
Combining INa blockade with IKur blockade produced synergistic anti-arrhythmic effects in human atria, which provides a potentially valuable strategy for the treatment of AF.
